These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2206786)

  • 1. Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.
    Rey E; Pons G; Richard MO; Vauzelle F; D'Athis P; Chiron C; Dulac O; Beaumont D; Olive G
    Br J Clin Pharmacol; 1990 Aug; 30(2):253-7. PubMed ID: 2206786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin. Clinical pharmacokinetics.
    Rey E; Pons G; Olive G
    Clin Pharmacokinet; 1992 Oct; 23(4):267-78. PubMed ID: 1395360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the individual enantiomers of vigabatrin in neonates with uncontrolled seizures.
    Vauzelle-Kervroëdan F; Rey E; Pons G; d'Athis P; Chiron C; Dulac O; Dumas C; Olive G
    Br J Clin Pharmacol; 1996 Dec; 42(6):779-81. PubMed ID: 8971436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.
    Haegele KD; Schechter PJ
    Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma vigabatrin enantiomer ratios in adults and children.
    Nagarajan L; Schramm T; Appleton DB; Burke CJ; Eadie MJ
    Clin Exp Neurol; 1993; 30():127-36. PubMed ID: 7712623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of vigabatrin: implications of creatinine clearance.
    Haegele KD; Huebert ND; Ebel M; Tell GP; Schechter PJ
    Clin Pharmacol Ther; 1988 Nov; 44(5):558-65. PubMed ID: 3180638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.
    Jacqz-Aigrain E; Guillonneau M; Rey E; Macher MA; Montes C; Chiron C; Loirat C
    Br J Clin Pharmacol; 1997 Aug; 44(2):183-5. PubMed ID: 9278207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passage of S(+) and R(-) gamma-vinyl-GABA across the human isolated perfused placenta.
    Challier JC; Rey E; Bintein T; Olive G
    Br J Clin Pharmacol; 1992 Aug; 34(2):139-43. PubMed ID: 1419475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of vigabatrin.
    Schechter PJ
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):19S-22S. PubMed ID: 2667604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of vigabatrin following single and multiple oral doses in normal volunteers.
    Hoke JF; Yuh L; Antony KK; Okerholm RA; Elberfeld JM; Sussman NM
    J Clin Pharmacol; 1993 May; 33(5):458-62. PubMed ID: 8331204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of food on the absorption of vigabatrin.
    Frisk-Holmberg M; Kerth P; Meyer P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):23S-25S. PubMed ID: 2757905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vigabatrin on the pharmacokinetics of carbamazepine.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I; Llopis P
    J Clin Pharm Ther; 2002 Dec; 27(6):427-30. PubMed ID: 12472982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients.
    Pitkänen A; Matilainen R; Ruutiainen T; Lehtinen M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1395-400. PubMed ID: 2853206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy.
    Dam M
    Epilepsia; 1989; 30 Suppl 3():S26-30. PubMed ID: 2767017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin--interference with urinary amino acid analysis.
    Preece MA; Sewell IJ; Taylor JA; Green A
    Clin Chim Acta; 1993 Sep; 218(1):113-6. PubMed ID: 8299214
    [No Abstract]   [Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin--plasma enantiomer concentrations and clinical effects.
    Sheean G; Schramm T; Anderson DS; Eadie MJ
    Clin Exp Neurol; 1992; 29():107-16. PubMed ID: 1343855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gas chromatographic assay of vigabatrin enantiomers in plasma.
    Schramm TM; McKinnon GE; Eadie MJ
    J Chromatogr; 1993 Jun; 616(1):39-44. PubMed ID: 8376491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.
    Tran A; O'Mahoney T; Rey E; Mai J; Mumford JP; Olive G
    Br J Clin Pharmacol; 1998 Apr; 45(4):409-11. PubMed ID: 9578192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of GABA and vigabatrin in human plasma by a rapid and simple HPLC method: correlation between clinical response to vigabatrin and increase in plasma GABA.
    Löscher W; Fassbender CP; Gram L; Gramer M; Hörstermann D; Zahner B; Stefan H
    Epilepsy Res; 1993 Mar; 14(3):245-55. PubMed ID: 8504795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.